Since its inception, our company has precisely targeted the small molecule bioactive peptide market, starting with basic peptide research and development and small-batch customized synthesis services. We have gradually accumulated extensive industry experience and transformed from a single R&D service provider into a full-industry-chain enterprise. The company has gradually developed into a comprehensive peptide technology enterprise integrating R&D, production, sales, and service, consistently keeping abreast of industry policies and market demands, and steadily promoting the standardization, refinement, and internationalization of the peptide industry.